3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
39
Stomach Neoplasms
29
Rectal Neoplasms
21
Pancreatic Neoplasms
19
Colonic Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
14
Esophageal Neoplasms
13
Adenocarcinoma Of Esophagus
12
Carcinoma, Non-Small-Cell Lung
11
Neoplasms
9
Neoplasm Metastasis
9
Adenocarcinoma
9
Cholangiocarcinoma
8
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Ovarian Neoplasms
6
Biliary Tract Neoplasms
6
Esophageal Squamous Cell Carcinoma
4
Endometrial Neoplasms
4
Carcinoma, Hepatocellular
4
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Gallbladder Neoplasms
3
Carcinoma
3
Bile Duct Neoplasms
3
Advanced Solid Tumors
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Interventions
pasireotide
1
lutetium Lu 177 dotatate
1
lanreotide
1
amino-acid, glucose, and electrolyte solution
1
Sunitinib
1
Octreotide
1
Everolimus
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
Oxaliplatin
×
90 days
×
Clear all
No trials found.